William Blair analyst Brian Weinstein chimed in today on Sequenom, Inc. (NASDAQ:SQNM), following the news that the Supreme Court rejected Sequenom’s appeal of a prior ruling invalidating …
William Blair analyst Brian Weinstein weighed in with his views on Sequenom, Inc. (NASDAQ:SQNM), after the company announced that Chief Scientific and Strategy Officer Dirk van den …
In a research report issued on Friday, William Blair analyst Brian Weinstein offered some insights EXACT Sciences Corporation (NASDAQ:EXAS) following the company’s first investor day held yesterday. …
William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), as the company announced a bought deal for 4 million shares of …
William Blair analyst Brian Weinstein reiterated an Outperfom rating on Sequenom (NASDAQ:SQNM), following the news that Sequenom and Illumina reached an agreement to settle all pending IP claims …
William Blair analyst Brian Weinstein maintained an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that UnitedHealth (NYSE:UNH) issued an updated medical policy on …
In a research report released Wednesday, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following the news that the Centers …
In a research report issued today, William Blair analyst Brian Weinstein maintained an Outperform rating on Cepheid (NASDAQ:CPHD). No price target was provided.
In a research report sent to investors today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Exact Sciences (NASDAQ:EXAS), following yesterday’s news that …
In a research report issued today, William Blair analyst Brian Weinstein reiterated an Outperform rating on Becton, Dickinson and Co (NYSE:BDX). No price …